We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,577,329 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.82 | 68.12B |
TIDMGSK
RNS Number : 3754M
GlaxoSmithKline PLC
06 May 2015
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
I give below details of a change in the interests of the under-mentioned Person Discharging Managerial Responsibilities in the Ordinary shares of GlaxoSmithKline plc (the "Company"):
Ms E Walmsley Following the vesting on 1 May 2015 of 25% of an award made on 1 May 2010 under the GlaxoSmithKline Deferred Investment Award Plan ('the Plan'), Ms Walmsley will receive a cash payment of 1505 pence per Ordinary share in respect of 13,669.339 notional Ordinary shares on 20 May 2015.
The Company and the above-mentioned individual were advised of this transaction on 6 May 2015.
This notification relates to a transaction notified in accordance with paragraph 3.1.4R(1)(a) of the Disclosure and Transparency Rules.
V A Whyte
Company Secretary
6 May 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSXQLFBEEFFBBQ
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions